LSA
NVO

Leonteq Securities AG’s Novo Nordisk NVO Stock Holding History

Leonteq Securities AG’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-300,000
Closed -$11M – 1352
2026
Q1 		$11M Buy
+300,000
New +$14.2M 0.41% 52
2025
Q4 		– Sell
-100,000
Closed -$5.55M – 1500
2025
Q3 		$5.55M Buy
+100,000
New +$5.85M 0.17% 100

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
GIM
Generate Investment Management Auckland, New Zealand $2.43B AUM 37.24% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Leonteq Securities AG's NVO Position: Q2 2026 in Review

Leonteq Securities AG reduced its Novo Nordisk (NVO) stake by 81% in Q2 2026, selling an estimated $5.35M and leaving 28,796 shares worth $1.38M. The position accounts for 0.05% of the portfolio, ranked #223.

Leonteq Securities AG first reported a position in NVO in Q4 2020 and has held it in 21 quarters since. The position peaked at $22.1M in Q2 2025. 466 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Leonteq Securities AG held 28,796 shares of Novo Nordisk worth $1.38M as of Q2 2026.
  • Leonteq Securities AG sold 124,447 Novo Nordisk shares in Q2 2026, an estimated $5.35M.
  • Novo Nordisk made up 0.05% of Leonteq Securities AG's portfolio in Q2 2026, its #223 holding.
  • Leonteq Securities AG first reported a position in Novo Nordisk in Q4 2020 and has held it in 21 quarters since.
  • Leonteq Securities AG's Novo Nordisk position peaked at $22.1M in Q2 2025.
  • 466 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.